CBD oil for consumer health refers to the usage of CBD oil-containing goods for various health and wellness purposes. CBD, short for cannabidiol, is a chemical constituent obtained from the hemp plant. In contrast to THC (tetrahydrocannabinol), CBD does not induce psychoactive effects and is not associated with addictive properties. It is derived from the hemp plant and is commonly employed in various consumer health commodities, including oils, tinctures, capsules, and topical remedies.
CBD-based products are gaining popularity in the health and wellness industry as scientific research shows CBD's medicinal qualities. It is used to treat a variety of psychiatric problems, including cancer and arthritis. The use of pharmacological medicines to treat anxiety and depression may result in sleepiness, sleeplessness, sexual dysfunction, and headaches. For instance, benzodiazepines are addictive and may lead to drug dependence. On the other hand, CBD oil is a natural method of treating anxiety and sadness that does not lead to addiction.
Furthermore, CBD has been shown to be useful in lowering the number of seizures. Nausea, vomiting, and post-cancer discomfort are common side effects experienced by cancer patients receiving chemotherapy or radiation therapies. Currently, studies on CBD's additional medicinal advantages are being done. If research is successful, CBD might be used to treat acne, type 1 diabetes, and other malignancies. As a result, the aforementioned aspect will increase demand in the global market.
Cannabidiol is derived from the Cannabis sativa plant's hemp and marijuana. These sources were deemed to have high THC concentrations, which can be harmful to the human body. As a result of the negative consequences of its use, most nations have controlled the cultivation and distribution of cannabidiol. Cannabidiol has been approved in various countries worldwide in recent years for industrial purposes, such as personal care and cosmetics, medicines, and food and beverages, after being shown to be safe for human consumption when eaten in the recommended proportion. Federal law in the United States has authorized the production and distribution of hemp-based CBD due to its medicinal benefits. Most European nations have legalized marijuana cultivation, creating an opportunity for start-ups dealing with marijuana-based products to enter the market.
North America is the most significant global cannabidiol oil consumer health market shareholder and is estimated to exhibit a CAGR of 24.2% over the forecast period. North America is often regarded as the most progressive region in terms of cannabis and its derivatives, including CBD. It boasts the biggest concentration of CBD firms and the most lenient legislation governing the use of CBD products. Although CBD usage is allowed in much of North America, restrictions vary from nation to nation. Northern sections of the continent are quite open to the usage of CBD products, cannabis, and hemp.
For instance, CBD is entirely legal in the United States and Canada. They are the worldwide leaders in the cannabis industry. However, the continent's lower areas, such as Central America and the Caribbean, have a different attitude regarding CBD products. They have highly stringent hemp legislation. Regardless of its non-psychoactive properties, hemp has been classified alongside marijuana. As a result, the use of hemp and cannabis-derived goods is still prohibited in the majority of North America's lower areas.
The key players in the global cannabidiol oil consumer health market are CV Sciences, Inc.; Medical Marijuana, Inc.; Elixinol; CHARLOTTE’S WEB; ENDOCA; Isodiol; NuLeaf Naturals, LLC; Joy Organics; Kazmira LLC; Lord Jones; Aurora Cannabis; Canopy Growth Corporation; IRIE CBD; Global Cannabinoids; CBD American Shaman; BioVectra; Bluebird Botanicals; Noramco, Inc.; CURE Pharmaceutical; GW Pharmaceutical; CIBDOL; CBDepot; THC Pharm GmbH., and others.